Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001388410-22-000007
Filing Date
2022-03-29
Accepted
2022-03-29 13:54:25
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5/A  
1 PRIMARY DOCUMENT primary_doc.xml 5/A 4052
  Complete submission text file 0001388410-22-000007.txt   5743
Mailing Address 3415 S SEPULVEDA BLVD SUITE 1100-6592 LOS ANGELES CA 90034
Business Address 3415 S SEPULVEDA BLVD SUITE 1100-6592 LOS ANGELES CA 90034 888-263-9799
PARALLAX HEALTH SCIENCES, INC. (Issuer) CIK: 0001388410 (see all company filings)

EIN.: 464733512 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8000 Services-Health Services

Mailing Address 3415 S SEPULVEDA BLVD STE 1100-1234 LOS ANGELES CA 90034
Business Address
BUCCI CALLI (Reporting) CIK: 0001621244 (see all company filings)

Type: 5/A | Act: 34 | File No.: 000-52534 | Film No.: 22779657